AMONGCredit Agreement • March 30th, 2000 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
INDENTUREIndenture • March 3rd, 2000 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
LEASELease Agreement • November 14th, 2000 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.36 CREDIT AGREEMENT AMONG GENZYME CORPORATION, THE SUBSIDIARY GUARANTORS PARTY HERETO, THE LENDERS PARTY HERETO, AND FLEET NATIONAL BANK, AS ADMINISTRATIVE AGENT, ABN AMRO BANK N.V., AS SYNDICATION AGENT AND THE BANK OF NOVA SCOTIA,...Credit Agreement • March 15th, 2004 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
Acquisition Proposal..........................................................35 Affiliates ....................................................................49 Agreemen t......................................................................1 Assign...Merger Agreement • August 13th, 2003 • Genzyme Corp • Biological products, (no disgnostic substances) • Delaware
ERISA.........................................................................23 ERISA Affiliate...............................................................23 Exchange Act...................................................................2 Expiration Date................................................................2 FDA...........................................................................17 FDCA..........................................................................17 Fee Conversion Options.........................................................9 FTC...........................................................................38 Fully Diluted Shares..........................................................54 GAAP..........................................................................15 Governmental Entity...........................................................14 HSR Act.......................................................................14 Indemnified Liability.......
4,000,000 SHARES GENZYME CORPORATION GENZYME TISSUE REPAIR DIVISION COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • October 30th, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • September 19th, 1995 • Genzyme Corp • Pharmaceutical preparations • New York
EXHIBIT 3 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated October 21, 1999, by and between FOCAL, INC., a Delaware corporation (the "Company"), and GENZYME CORPORATION, a Massachusetts corporation (the...Registration Rights Agreement • November 8th, 1999 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
LESSOR: WELLS FARGO BANK NORTHWEST, N.A. (formerly known as FIRST SECURITY BANK, N.A.) not in its individual capacity except as expressly set forth herein, but solely as Trustee under the Owner Trust Agreement dated as of October 21, 1998 By: /s/ Val...Lease Agreement • November 8th, 2005 • Genzyme Corp • Biological products, (no disgnostic substances)
Exhibit 10.5.1 FIRST AMENDMENT TO LEASE This FIRST AMENDMENT TO LEASE (this "First Amendment") is executed by and between KS Parcel D, LLC (the "Landlord"), a Delaware limited liability company, and Genzyme Corporation (the "Tenant"). Reference is...Lease • March 15th, 2005 • Genzyme Corp • Biological products, (no disgnostic substances)
1 EXHIBIT 10.4 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANTCommon Stock Purchase Warrant • November 14th, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER This Amendment No. 2 to Agreement and Plan of Merger (this "AMENDMENT") is made as of August 25, 2000, by and among Genzyme Corporation, a Massachusetts corporation ("GENZYME"), Seagull Merger...Agreement and Plan of Merger • September 13th, 2000 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
GENZYME CORPORATION 3% CONVERTIBLE SUBORDINATED DEBENTURES DUE 2021 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 11th, 2001 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
AMONGCredit Agreement • March 31st, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
1 EXHIBIT 4.5 GENZYME CORPORATION 5 1/4% Convertible Subordinated Notes Due 2005 PURCHASE AGREEMENTPurchase Agreement • July 21st, 1998 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
3,000,000 Shares GENZYME CORPORATION Genzyme Molecular Oncology Division Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • June 8th, 1998 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
LEASELease Agreement • November 14th, 2000 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT ACommon Stock Purchase Agreement • July 18th, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.46 *Confidential portions have been omitted and filed separately with the Commission. SUPPLY AGREEMENT THIS AGREEMENT is made as of the 7th day of February 1997 by and between BIOMATRIX, INC., a Delaware corporation, having its principal...Supply Agreement • April 1st, 2002 • Genzyme Corp • Biological products, (no disgnostic substances) • New Jersey
EXHIBIT 10.2Lease • August 8th, 2005 • Genzyme Corp • Biological products, (no disgnostic substances)
Exhibit 2.1 AGREEMENT AND PLAN OF MERGERMerger Agreement • February 27th, 2004 • Genzyme Corp • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.3.3 THIRD AMENDMENT TO LEASE AGREEMENT THIRD AMENDMENT TO LEASE AGREEMENT (the "Third Amendment") dated as of January 14, 2004 among and between Wells Fargo Bank Northwest, N.A. (formerly known as First Security Bank, N.A.), not in its...Lease Agreement • March 15th, 2004 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
and American Stock Transfer & Trust Company, Rights AgentRights Agreement • June 11th, 1999 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
1 EHXIBIT 4.15 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated February 27, 1997, by and between Genzyme Corporation, a Massachusetts corporation (the "COMPANY"), and Credit Suisse First Boston (Hong Kong) Ltd....Registration Rights Agreement • April 27th, 1998 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
1 EXHIBIT 10.3 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANTWarrant Agreement • November 14th, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
LEASE BETWEENLease Agreement • August 14th, 2002 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
ii) 4 AMENDED AND RESTATED RIGHTS AGREEMENTRights Agreement • May 1st, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
GENZYME CORPORATION $500,000,000 3.625% Senior Notes Due 2015 $500,000,000 5.000% Senior Notes Due 2020 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 17th, 2010 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
Genzyme Corporation, a Massachusetts corporation (the “Company”), proposes to issue and sell, upon the terms set forth in a purchase agreement, dated as of June 14, 2010 (the “Purchase Agreement”), U.S. $500,000,000 aggregate principal amount of its 3.625% Senior Notes Due 2015 (the “2015 Notes”) and U.S. $500,000,000 aggregate principal amount of its 5.000% Senior Notes Due 2020 (the “2020 Notes”) (the 2015 Notes and the 2020 Notes are collectively referred to herein as the “Initial Securities”) to the several initial purchasers named in Schedule A to the Purchase Agreement (collectively, the “Initial Purchasers”). The Initial Securities will be issued pursuant to an Indenture, dated as of even date herewith, between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as supplemented by the First Supplemental Indenture, dated as of even date herewith, among the Company, the Subsidiary Guarantor(s) party thereto from time to time and the Trustee
RECITALSSupplemental Agreement • January 2nd, 2001 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
THIRD AMENDED AND RESTATED RENEWED RIGHTS AGREEMENTRights Agreement • July 1st, 2003 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
THIRD AMENDED AND RESTATED RENEWED RIGHTS AGREEMENT Exhibit A—TERMS OF THE JUNIOR PARTICIPATING PREFERRED STOCK EXHIBIT B—FORM OF RIGHT CERTIFICATE TABLE OF CONTENTS
PURCHASE AGREEMENTPurchase Agreement • November 14th, 1997 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.47 *Confidential portions have been omitted and filed separately with the Commission. TRADEMARK LICENSE AGREEMENT THIS TRADEMARK LICENSE AGREEMENT (this "Agreement") is made as of this 7th day of February, 1997 by and between Biomatrix,...Trademark License Agreement • April 1st, 2002 • Genzyme Corp • Biological products, (no disgnostic substances) • New Jersey
EXHIBIT 2 STOCK PURCHASE AGREEMENT BY AND BETWEENStock Purchase Agreement • November 8th, 1999 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
PARTICULARS andSale Agreement • November 9th, 2001 • Genzyme Corp • Biological products, (no disgnostic substances)
FIRST SCHEDULE PREMISESLease Agreement • November 9th, 2001 • Genzyme Corp • Biological products, (no disgnostic substances)
